3008:
Anti-IL5 Therapies in Eosinophilic Disorders
Mast Cell/Eosinophilic Disorders
Sunday, March 4, 2018: 7:00 AM-8:00 AM
Hyatt, Convention Level, Celebration 7
1.00 CME/CE
Seminar
Primary Discussion Leaders:
Anna Kovalszki, MD
Praveen Akuthota, MD
Takao Fujisawa, MD FAAAAI

Learning Objectives:
  1. Describe indications for anti-IL5 therapy in various eosinophilic disorders
Handouts
  • AAAAI Handout AKPATF 2018.pdf (315.6 kB)
  • See more of: Session